welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
recruiting

Bisoprolol in DMD Early Cardiomyopathy

key information

study id #: NCT03779646

condition: Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated

status: recruiting

purpose:

This study aimed to use cardiac magnetic resonance imaging (CMR) to evaluate the efficacy and safety of bisoprolol therapy for boys with Duchenne muscular dystrophy (DMD) and preserved ejection fraction. On top of angiotensin-converting enzyme inhibitor (ACEI), half of the participants will receive bisoprolol in combination, while the other half will not receive any beta-blocker.

intervention: Bisoprolol Fumarate

mechanism of action: Beta-blocker to prevent cardiac function deterioration

results: https://clinicaltrials.gov/ct2/show/results/NCT03779646

last updated: December 04, 2019